Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma
Crossref DOI link: https://doi.org/10.1186/s40364-016-0061-8
Published Online: 2016-03-09
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rael, Efren
Rakszawski, Kevin
Koller, Kristian
Bayerl, Michael
Butte, Manish
Zheng, Hong